about
The potential of magneto-electric nanocarriers for drug deliveryCurrent status of non-viral gene therapy for CNS disorders.Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update.Towards detection and diagnosis of Ebola virus disease at point-of-care.Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected MacrophagesNano-biosensors to detect beta-amyloid for Alzheimer's disease management.Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.Recent trends on hydrogel based drug delivery systems for infectious diseasesIn vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression.Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS.Advancements in nano-enabled therapeutics for neuroHIV management.Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders.Recent treatment modalities for cardiovascular diseases with a focus on stem cells, aptamers, exosomes and nanomedicine.A sensitive electrochemical immunosensor for label-free detection of Zika-virus protein.Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug AbusersNanotechnology for the Treatment of NeuroAIDSCholesterol biosensors based on oxygen sensing alginate-silica microspheresA Small Molecule BH3-mimetic Suppresses Cigarette Smoke-Induced Mucous Expression in Airway Epithelial CellsCNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening
P50
Q30403718-0821CE8C-578B-426B-8D7B-CF7E8B05250EQ33824159-583D0A5D-FDCC-40B4-BEA0-720FFAEE3360Q35708840-DF9E19F7-EA71-4574-BE64-4859F8D0E46CQ36148222-89DD0C1B-049A-4AFE-8A48-50424AB6F73EQ37019304-5DEE87DC-7D64-4165-94FC-200453C09E88Q38724884-1D198AAD-E37A-4FB6-A665-99E1E1141EFFQ38761022-4B76F6FD-05DA-4F38-81C8-2F7C06BBC375Q38810357-20CD8C90-5BA0-4E4F-875D-FA8A9446B372Q39635767-71563D47-5604-4444-AC8A-B892AB0A29EAQ40111779-8E363120-F7D6-45D2-BAF9-FDED8B58F1E8Q40542601-3E949F81-FDBA-40CD-8365-0F58FF332ED0Q49612238-B917C9C2-004E-4660-9273-E965BFEBD12BQ49982118-F625E223-98FA-493E-91FB-0B584F753F83Q55512220-077A808D-F4CC-4313-8613-0A30BF6742D9Q56777442-F796DB55-934F-4F20-B922-74C8C7D957F4Q56777455-83E3E769-E23D-4452-BB7C-2A5EC4CBA929Q56777465-3DAE787B-5B11-435A-8E54-C0ECD23FC4D8Q58740933-A3E22516-9B92-41F1-B0DD-6A08926C33CDQ91548046-DE7627B9-918D-49B5-8F26-C7BD98889A5F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rahul Dev Jayant
@ast
Rahul Dev Jayant
@de
Rahul Dev Jayant
@en
Rahul Dev Jayant
@es
Rahul Dev Jayant
@nl
Rahul Dev Jayant
@sl
Rahul Dev Jayant
@sq
type
label
Rahul Dev Jayant
@ast
Rahul Dev Jayant
@de
Rahul Dev Jayant
@en
Rahul Dev Jayant
@es
Rahul Dev Jayant
@nl
Rahul Dev Jayant
@sl
Rahul Dev Jayant
@sq
prefLabel
Rahul Dev Jayant
@ast
Rahul Dev Jayant
@de
Rahul Dev Jayant
@en
Rahul Dev Jayant
@es
Rahul Dev Jayant
@nl
Rahul Dev Jayant
@sl
Rahul Dev Jayant
@sq
P108
P227
P108
P214
6362154801913456310002
P227
1175636924
P31
P496
0000-0002-2584-3878
P7859
lccn-n2018184910